Delivery Order SPE2DB20D2014-SPE2DB25FA24D

Award Date 10/31/24
Potential Completion Date 11/1/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of NovologTM 100 Unit/mL FlexPen 3mL medical devices to the Defense Logistics Agency (DLA). The $2,831.62 firm-fixed-price delivery order was issued to the prime contractor, AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 22, 2024 and was awarded on November 21, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of NovologTM 100 unit/mL FlexPen 3mL to the Defense Logistics Agency (DLA). The $1,329.99 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 25, 2022, with a completion date of March 28, 2022. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical supplies to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $1,757.25. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of NovologTM 100 Unit/mL FlexPen 3mL, a prescription medication used to treat diabetes. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $7,978.29 and an ultimate completion date of February 25, 2022. It is a delivery order contract with a firm fixed price pricing type....
This federal contract award, valued at $1,498.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Novolog® 100 unit/mL FlexPen 3mL, a diabetes medication. This is a Firm Fixed Price Delivery Order contract with a completion date of November 7, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,080.74 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication. The contract has an ultimate completion date of October 21, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Novolog 100 Unit/mL FlexPen 3mL insulin products. The $1,810.80 fixed-price delivery order has a completion date of September 27, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as the primary vehicle for providing...
This federal contract award is for the delivery of NovologTM 100 unit/mL FlexPen 3mL, an insulin medication, to the Defense Logistics Agency (DLA). The contract, valued at $3,537.60, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,110.78 firm fixed-price delivery order is for the supply of Novolog 100 Unit/mL Flexpen 3mL, a medication used for diabetes management. The contract has an ultimate completion date of November 7, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award is for the delivery of NovologTM 100 unit/mL FlexPenTM 3mL, a prescription medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 3, 2024 with a ceiling value of $2,578.20 and a completion date of July 5, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA24D
    Delivery Order

This federal contract award is for the delivery of NovologTM 100 unit/mL FlexPen 3mL, a prescription medication used to treat diabetes. The $1,911.12 delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract has a firm fixed price and runs through November 1, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's critical role in supplying essential medical products to federal government agencies, particularly the Department of Defense and veterans' healthcare programs.

Generated 1/30/25, 9:18 AM